Bay Street News, November, 2018

Licensed Jenrin Discovery’s extensive library of small molecules targeting the endocannabinoid system (ECS) positioning Corbus with the leading pipeline focused […]

HAIFA, Israel, Nov. 08, 2018 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel […]

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company […]

NEW YORK, Nov. 08, 2018 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]

Results Demonstrate that Benefits of Filament Merger Are on TrackInitiatives Successfully Positioning Lifetime for Long Term ProfitabilityDeclares Regular Quarterly Dividend […]

RESEARCH TRIANGLE PARK, N.C., Nov. 08, 2018 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will […]

EWING, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President […]

LATHAM, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leader in providing energy solutions that […]

Results to be presented show a significant reduction of Lp(a) levels, favorable safety and tolerability profile BOSTON and CARLSBAD, Calif., […]

– Conference Call at 8:30 a.m. ET Today – DURHAM, N.C., Nov. 08, 2018 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical […]